文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Imaging through PSMA-targeted PET in patients diagnosed with radioiodine-refractory thyroid cancer, a flash in the pan or a game changer?

作者信息

Rizzo Alessio, Piccardo Arnoldo, Treglia Giorgio

机构信息

Department of Nuclear Medicine, Candiolo Cancer Institute, FPO - IRCCS, 10060, Turin, Italy.

Nuclear Medicine Department, E.O. "Ospedali Galliera", 16128, Genoa, Italy.

出版信息

Endocrine. 2024 Aug;85(2):601-603. doi: 10.1007/s12020-024-03748-w. Epub 2024 Feb 28.

DOI:10.1007/s12020-024-03748-w
PMID:38416379
Abstract
摘要

相似文献

[1]
Imaging through PSMA-targeted PET in patients diagnosed with radioiodine-refractory thyroid cancer, a flash in the pan or a game changer?

Endocrine. 2024-8

[2]
The prostate-specific membrane antigen (PSMA)-targeted radiotracer F-DCFPyL detects tumor neovasculature in metastatic, advanced, radioiodine-refractory, differentiated thyroid cancer.

Med Oncol. 2020-10-9

[3]
First evidence of PSMA expression in differentiated thyroid cancer using [⁶⁸Ga]PSMA-HBED-CC PET/CT.

Eur J Nucl Med Mol Imaging. 2015-9

[4]
PSMA Expression in Differentiated Thyroid Cancer: Association With Radioiodine, 18FDG Uptake, and Patient Outcome.

J Clin Endocrinol Metab. 2021-11-19

[5]
Prostate-Specific Membrane Antigen Expression in Patients With Differentiated Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy Using 68Ga-PSMA-HBED-CC PET/CT.

Clin Nucl Med. 2021-8-1

[6]
PSMA Expression in Papillary Thyroid Carcinoma: Opening a New Horizon in Management of Thyroid Cancer?

Clin Nucl Med. 2016-5

[7]
Assessing Krenning's score on 68 Ga-DOTATATE PET-CT and miPSMA score on 68 Ga-PSMA-11 PET-CT in TENIS: a comparison with FDG PET/CT and examining the feasibility of targeted radionuclide therapy.

Nucl Med Commun. 2024-8-1

[8]
PSMA-Avid Liver Metastasis in a Case of Prostate Carcinoma and Poorly Differentiated Thyroid Carcinoma.

Clin Nucl Med. 2024-8-1

[9]
Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.

Eur Urol Oncol. 2018-5-15

[10]
[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH.

Eur J Nucl Med Mol Imaging. 2012-6

引用本文的文献

[1]
Targeting Surface Markers in Anaplastic Thyroid Cancer: Future Directions in Ligand-bound Therapy.

J Endocr Soc. 2025-2-27

本文引用的文献

[1]
The complementary role of PSMA expression and [F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology.

EJNMMI Res. 2023-6-1

[2]
Ga-68 Prostate-Specific Membrane Antigen-HBED-CC Positron Emission Tomography/Computed Tomography in Anaplastic Thyroid Carcinoma.

Indian J Nucl Med. 2022

[3]
Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review.

Diagnostics (Basel). 2023-2-3

[4]
Molecular features of aggressive thyroid cancer.

Front Oncol. 2022-12-20

[5]
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?

Cancers (Basel). 2022-8-21

[6]
[Ga]Ga-PSMA Versus [F]PSMA Positron Emission Tomography/Computed Tomography in the Staging of Primary and Recurrent Prostate Cancer. A Systematic Review of the Literature.

Eur Urol Oncol. 2022-6

[7]
Head-to-Head Comparison of Ga-PSMA-11 and I in the Follow-Up of Well-Differentiated Metastatic Thyroid Cancer: A New Potential Theragnostic Agent.

Front Endocrinol (Lausanne). 2021

[8]
Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer-A New Diagnostic and Therapeutic Target?

Cancers (Basel). 2021-11-14

[9]
Prostate-Specific Membrane Antigen Expression in Patients With Differentiated Thyroid Cancer With Thyroglobulin Elevation and Negative Iodine Scintigraphy Using 68Ga-PSMA-HBED-CC PET/CT.

Clin Nucl Med. 2021-8-1

[10]
Gallium-68 prostate-specific membrane antigen ([Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study.

EJNMMI Res. 2020-10-22

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索